Speaker Spotlight: Dr. Akanksha Pandey at the 12th International Cancer, Oncology & Therapy Conference 2026

 

Speaker Spotlight: Dr. Akanksha Pandey at the 12th International Cancer, Oncology & Therapy Conference 2026

The 12th International Cancer, Oncology & Therapy Conference 2026 (CANCERUCG 2026) is set to bring together leading oncologists, pathologists, clinicians, researchers, and healthcare professionals from across the world to discuss the latest developments in cancer research, diagnosis, and therapeutic advancements. Scheduled to take place April 09–11, 2026, in Dubai, UAE, the conference will provide a global platform for scientific exchange, collaboration, and innovation in oncology and related medical fields.

Among the distinguished speakers participating in this prestigious event is Dr. Akanksha Pandey, an accomplished academician and pathologist from Heritage Institute of Medical Sciences (HIMS), Varanasi, India. Dr. Pandey will be presenting a compelling case study titled “A Rare Case of Placental Chorioangioma with No Fetal Cardiac Complications.” Her presentation will shed light on an uncommon clinical scenario that contributes to a deeper understanding of placental pathology and its potential implications for maternal and fetal health.

Understanding Placental Chorioangioma

Placental chorioangioma is considered the most common benign tumor of the placenta, although it remains relatively rare in clinical practice. These tumors originate from the vascular tissue of the placenta and are often discovered incidentally during routine prenatal examinations or after delivery through pathological analysis.

While many small chorioangiomas remain asymptomatic and do not affect pregnancy outcomes, larger tumors can sometimes lead to significant complications. In certain cases, they may contribute to fetal anemia, hydrops fetalis, polyhydramnios, and fetal cardiac overload, which can adversely affect the health of both the mother and the fetus. Because of these potential complications, early detection and accurate diagnosis are essential for effective clinical management.

Dr. Pandey’s research focuses on a rare presentation of placental chorioangioma where no fetal cardiac complications were observed, making it an important contribution to medical literature. The case highlights the complexity of placental tumors and emphasizes the need for careful pathological evaluation and multidisciplinary clinical assessment. Through detailed histopathological examination and clinical correlation, the study provides valuable insights into the natural progression and clinical significance of this rare condition.

Clinical and Research Significance

Case studies like the one presented by Dr. Pandey are particularly valuable in the field of pathology and oncology-related research, as they expand the collective understanding of rare conditions and their outcomes. Even though placental tumors are not directly related to oncology in the traditional sense, their cellular growth patterns, vascular characteristics, and diagnostic evaluation often intersect with broader pathological research, including tumor biology and molecular diagnostics.

By sharing this case with the global medical community, Dr. Pandey contributes to improved diagnostic awareness and encourages clinicians and researchers to consider a broader spectrum of possibilities when evaluating placental abnormalities. Such insights can help refine prenatal diagnostic techniques, pathological classification, and patient management strategies, ultimately improving healthcare outcomes.

About Dr. Akanksha Pandey

Dr. Akanksha Pandey is a dedicated medical professional and researcher with a strong academic background in pathology. She completed her Bachelor of Medicine and Bachelor of Surgery (MBBS) from Pondicherry University in 2012, after which she pursued her specialization in pathology. She obtained her Doctor of Medicine (MD) in Pathology in 2019 from Padmashree Dr. D. Y. Patil University, Navi Mumbai.

Currently, Dr. Pandey serves as an Assistant Professor in the Department of Pathology at the Heritage Institute of Medical Sciences (HIMS), Varanasi, India. In this role, she actively contributes to medical education, diagnostic pathology, and clinical research, mentoring students while also engaging in scholarly work that advances the understanding of pathological diseases.

Dr. Pandey has authored more than five research publications in national and international journals, demonstrating her commitment to scientific inquiry and evidence-based medicine. Her academic work reflects a strong focus on onychopathology, which involves the microscopic and molecular study of tumors and cancer-related diseases.

In addition to onychopathology, she has developed specialized interests in gastrointestinal (GI) pathology and molecular pathology. These areas are increasingly important in modern medicine, as molecular diagnostics and genetic profiling are transforming the way cancers are detected, classified, and treated. By integrating traditional histopathological methods with advanced molecular techniques, pathologists like Dr. Pandey are helping to pave the way for precision medicine and personalized treatment approaches.

Contribution to the Global Oncology Community

The 12th International Cancer, Oncology & Therapy Conference 2026 serves as a vital platform for the exchange of innovative ideas and groundbreaking research in oncology and related medical sciences. The conference will feature keynote lectures, scientific sessions, poster presentations, and panel discussions addressing critical topics such as cancer diagnosis, targeted therapies, immunotherapy, molecular oncology, and emerging treatment technologies.

Speakers like Dr. Pandey play a crucial role in enriching the scientific program by presenting unique case studies and research findings that broaden the collective knowledge of the global medical community. Her presentation highlights the importance of pathology as the foundation of accurate diagnosis and effective treatment planning, reinforcing the central role of pathologists in multidisciplinary healthcare teams.

Join the Conference

Healthcare professionals, researchers, academicians, and students are invited to participate in the 12th International Cancer, Oncology & Therapy Conference 2026 and engage with experts from around the world. The event offers an exceptional opportunity to learn about the latest scientific developments, share research findings, and build meaningful collaborations within the global oncology community.

📅 Conference Dates: April 09–11, 2026

📍 Location: Dubai, UAE

🌐 Virtual Participation: Available for international attendees

By bringing together leading experts and emerging researchers, the conference aims to advance scientific knowledge, inspire innovation, and strengthen global efforts in the fight against cancer and related diseases.

#DrAkankshaPandey #SpeakerDrAkankshaPandey #AkankshaPandey #MeetDrAkankshaPandeym#FeaturedSpeakerDrAkankshaPandey #SpeakerSpotlight #ConferenceSpeaker #OncologySpeaker#PathologySpeaker #WomenInMedicine #WomenInScience#MedicalResearcher #OncopathologyExpert #MolecularPathology #GIPathology #MedicalConferenceSpeaker #CancerConference2026#CancerUCG2026 #OncologyConference #GlobalMedicalCommunity #HealthcareExperts #ScientificSpeakers #ResearchPresentation #MedicalInnovation #UCGConferences

Comments

Post a Comment

Popular posts from this blog

Nursing Innovation in Oncology: Advancing Patient-Centered Cancer Care

Image
  Nursing Innovation in Oncology: Advancing Patient-Centered Cancer Care 11th International Cancer, Oncology and Therapy Conference 📍 Dubai, UAE | 📅 September 02–04, 2025 In the ever-evolving world of oncology, the role of nurses has expanded far beyond conventional caregiving. Today’s oncology nurses are pivotal in driving innovation, advocating for patients, and delivering care that is not only clinically effective but also emotionally responsive and culturally competent. As we look ahead to the 11th International Cancer, Oncology and Therapy Conference (ICOT 2025) in Dubai, UAE , it is imperative to shine a light on the transformative power of nursing innovation in advancing patient-centered cancer care . 🌟 The Evolving Role of the Oncology Nurse Oncology nursing has undergone a significant transformation in the past decade. No longer confined to hospital wards or chemotherapy units, oncology nurses are now active contributors in clinical trials, digital healt...
Read more

The Role of Immunotherapy in Advanced Liver Cancer

Image
  The Role of Immunotherapy in Advanced Liver Cancer 11th International Cancer, Oncology and Therapy Conference | September 02-04, 2025 | Dubai, UAE & Online https://cancer.utilitarianconferences.com Introduction Liver cancer, particularly hepatocellular carcinoma (HCC), remains one of the most challenging malignancies worldwide due to its asymptomatic nature in early stages, limited treatment options, and poor prognosis in advanced stages. While traditional treatments such as surgery, chemotherapy, and targeted therapies have provided limited success in advanced cases, immunotherapy has emerged as a beacon of hope for transforming the treatment landscape. As we prepare for the 11th International Cancer, Oncology and Therapy Conference (11CANCERUCG2025) , held from September 02–04, 2025 in Dubai, UAE , leading researchers, oncologists, and healthcare professionals will gather to explore cutting-edge developments in cancer care — with a major focus on revolutionizing ...
Read more
Image
  Pancreatic Cancer and Diet: Foods That Help Support Your Health Pancreatic cancer is one of the most challenging cancers to detect and treat, often progressing silently until it reaches an advanced stage. While medical treatment such as surgery, chemotherapy, or radiation therapy plays a critical role, diet and nutrition can be powerful allies in supporting health, improving quality of life, and potentially influencing outcomes. In this blog, we’ll explore how pancreatic cancer affects nutritional needs, which foods can support your health, and how to approach eating during and after treatment. Why Diet Matters in Pancreatic Cancer The pancreas plays a central role in digestion by producing enzymes that help break down food and hormones like insulin that regulate blood sugar. When cancer affects this organ, both digestion and metabolism can be disrupted. Common symptoms such as loss of appetite, weight loss, fatigue, nausea, diarrhea, or poor nutrient absorption c...
Read more